Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Autoimmune Disorders

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    January 2012
  1. ROSSI S , Furlan R, De Chiara V, Motta C, et al
    Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis.
    Ann Neurol. 2012;71:76-83.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  2. OKSENBERG JR , Hauser SL
    Decoding multiple sclerosis.
    Ann Neurol. 2011;70:A5-7.
    PubMed     Text format     Related articles   



  3. PATSOPOULOS NA , de Bakker PI
    Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
    Ann Neurol. 2011;70:897-912.
    PubMed     Text format     Related articles    Abstract available



  4. BLANKENHORN EP , Butterfield R, Case LK, Wall EH, et al
    Genetics of experimental allergic encephalomyelitis supports the role of T helper cells in multiple sclerosis pathogenesis.
    Ann Neurol. 2011;70:887-96.
    PubMed     Text format     Related articles    Abstract available



  5. RAMAGOPALAN SV , Dyment DA, Cader MZ, Morrison KM, et al
    Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
    Ann Neurol. 2011;70:881-6.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  6. MOLL NM , Rietsch AM, Thomas S, Ransohoff AJ, et al
    Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations.
    Ann Neurol. 2011;70:764-73.
    PubMed     Text format     Related articles    Abstract available



  7. BOZIC C , Richman S, Plavina T, Natarajan A, et al
    Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1.
    Ann Neurol. 2011;70:713-21.
    PubMed     Text format     Related articles    Abstract available



  8. PONSONBY AL , Lucas RM
    Shift work and multiple sclerosis.
    Ann Neurol. 2011;70:680-3.
    PubMed     Text format     Related articles   



    October 2011
  9. HEDSTROM AK , Akerstedt T, Hillert J, Olsson T, et al
    Shift work at young age is associated with increased risk for multiple sclerosis.
    Ann Neurol. 2011 Oct 17. doi: 10.1002/ana.22597.
    PubMed     Text format     Related articles    Abstract available



  10. WINKELMANN A , Loebermann M, Reisinger EC, Peter Hartung H, et al
    Fingolimod treatment for multiple sclerosis Patients What Do We Do with Varicella?
    Ann Neurol. 2011;70:673-4.
    PubMed     Text format     Related articles   



  11. GIOVANNA BRUNASSO AM , Fancelli L, Massone C
    Etanercept as steroid-sparing agent in dermatomyositis.
    Ann Neurol. 2011;70:670-1.
    PubMed     Text format     Related articles   



  12. QIAN P , Cadavid D, Wolansky LJ, Cook SD, et al
    Heterogeneity in longitudinal evolution of ring-enhancing multiple sclerosis lesions.
    Ann Neurol. 2011;70:668-9.
    PubMed     Text format     Related articles   



  13. BUSTAMANTE MF , Fissolo N, Rio J, Espejo C, et al
    Implication of the toll-like receptor 4 pathway in the response to interferon-beta in multiple sclerosis.
    Ann Neurol. 2011;70:634-45.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  14. SERAFINI B , Cavalcante P, Bernasconi P, Aloisi F, et al
    Epstein-barr virus in myasthenia gravis thymus: A matter of debate.
    Ann Neurol. 2011;70:519.
    PubMed     Text format     Related articles   



  15. MEYER M , Hols AK, Liersch B, Leistner R, et al
    Lack of evidence for epstein-barr virus infection in myasthenia gravis thymus.
    Ann Neurol. 2011;70:515-8.
    PubMed     Text format     Related articles    Abstract available



  16. KAKALACHEVA K , Maurer MA, Tackenberg B, Munz C, et al
    Intrathymic epstein-barr virus infection is not a prominent feature of myasthenia gravis.
    Ann Neurol. 2011;70:508-14.
    PubMed     Text format     Related articles    Abstract available



  17. STEINER I
    On human disease and animal models.
    Ann Neurol. 2011;70:343-4.
    PubMed     Text format     Related articles   



  18. TUMANI H , Deisenhammer F, Giovannoni G, Gold R, et al
    Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.
    Ann Neurol. 2011;70:520.
    PubMed     Text format     Related articles   



    July 2011
  19. GALEA I , Freedman MS, Thompson EJ
    Cerebrospinal fluid analysis in the 2010 revised McDonald's multiple sclerosis diagnostic criteria.
    Ann Neurol. 2011;70:183.
    PubMed     Text format     Related articles   



  20. CENTONZE D , Floris R, Stefanini M, Rossi S, et al
    Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity.
    Ann Neurol. 2011;70:52-9.
    PubMed     Text format     Related articles    Abstract available



  21. MIRZAEI F , Michels KB, Munger K, O'Reilly E, et al
    Gestational vitamin D and the risk of multiple sclerosis in offspring.
    Ann Neurol. 2011;70:30-40.
    PubMed     Text format     Related articles    Abstract available



  22. CUTTER G , Salter A
    Got milk?
    Ann Neurol. 2011;70:3-4.
    PubMed     Text format     Related articles   



    June 2011
  23. VAN DER KOP ML , Pearce MS, Dahlgren L, Synnes A, et al
    Neonatal and delivery outcomes in women with multiple sclerosis.
    Ann Neurol. 2011 Jun 27. doi: 10.1002/ana.22483.
    PubMed     Text format     Related articles    Abstract available



  24. LASSMANN H
    A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.
    Ann Neurol. 2011 Jun 2. doi: 10.1002/ana.22494.
    PubMed     Text format     Related articles   



  25. ZIVADINOV R , Ramanathan M, Dwyer MG, Marr K, et al
    Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset".
    Ann Neurol. 2011;69:1062-3.
    PubMed     Text format     Related articles   



  26. KOEL-SIMMELINK MJ , Teunissen CE, Behradkia P, Blankenstein MA, et al
    The neurofilament light chain is not stable in vitro.
    Ann Neurol. 2011;69:1065-6.
    PubMed     Text format     Related articles   



  27. GARCES-SANCHEZ M , Laughlin RS, Dyck PJ, Engelstad JK, et al
    Painless diabetic motor neuropathy: a variant of diabetic lumbosacral radiculoplexus Neuropathy?
    Ann Neurol. 2011;69:1043-54.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  28. KILSDONK ID , Barkhof F, Wattjes MP
    2010 revisions to mcDonald criteria for diagnosis of multiple sclerosis: Impact of 3-tesla magnetic resonance imaging.
    Ann Neurol. 2011 May 26. doi: 10.1002/ana.22490.
    PubMed     Text format     Related articles   




  29. A randomized, pilot trial of etanercept in dermatomyositis.
    Ann Neurol. 2011 May 11. doi: 10.1002/ana.22477.
    PubMed     Text format     Related articles    Abstract available



  30. GAITAN MI , Shea CD, Evangelou IE, Stone RD, et al
    Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions.
    Ann Neurol. 2011 May 11. doi: 10.1002/ana.22472.
    PubMed     Text format     Related articles    Abstract available



  31. COHEN JA , Chun J
    Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.
    Ann Neurol. 2011;69:759-77.
    PubMed     Text format     Related articles   



    April 2011
  32. GIAMPIERO A
    Chronic cerebrospinal venous insufficiency and susceptibility to multiple sclerosis.
    Ann Neurol. 2011 Apr 12. doi: 10.1002/ana.22451.
    PubMed     Text format     Related articles   



  33. AXTHELM MK , Bourdette DN, Marracci GH, Su W, et al
    Japanese macaque encephalomyelitis: A spontaneous multiple sclerosis-like disease in a nonhuman primate.
    Ann Neurol. 2011 Apr 7. doi: 10.1002/ana.22449.
    PubMed     Text format     Related articles    Abstract available



  34. KREMER D , Aktas O, Hartung HP, Kury P, et al
    The complex world of oligodendroglial differentiation inhibitors.
    Ann Neurol. 2011;69:602-18.
    PubMed     Text format     Related articles    Abstract available



  35. HAO J , Campagnolo D, Liu R, Piao W, et al
    Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.
    Ann Neurol. 2011;69:721-34.
    PubMed     Text format     Related articles    Abstract available



  36. ZAHEDNASAB H , Bahreini SA
    Interferon-beta and toll-like receptor-9 processing.
    Ann Neurol. 2011;69:740-1.
    PubMed     Text format     Related articles   



    March 2011
  37. CAMPBELL GR , Ziabreva I, Reeve AK, Krishnan KJ, et al
    Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
    Ann Neurol. 2011;69:481-92.
    PubMed     Text format     Related articles    Abstract available



  38. DUTTA R , Chang A, Doud MK, Kidd GJ, et al
    Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
    Ann Neurol. 2011;69:445-54.
    PubMed     Text format     Related articles    Abstract available



  39. AKTAS O , Hartung HP
    Beyond axonal transection: Hippocampal damage in multiple sclerosis.
    Ann Neurol. 2011;69:433-6.
    PubMed     Text format     Related articles   



    February 2011
  40. HIGUCHI O , Hamuro J, Motomura M, Yamanashi Y, et al
    Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Ann Neurol. 2011;69:418-22.
    PubMed     Text format     Related articles    Abstract available



  41. MEHLING M , Hilbert P, Fritz S, Durovic B, et al
    Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients.
    Ann Neurol. 2011;69:408-13.
    PubMed     Text format     Related articles    Abstract available



  42. LANCASTER E , Huijbers MG, Bar V, Boronat A, et al
    Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.
    Ann Neurol. 2011;69:303-11.
    PubMed     Text format     Related articles    Abstract available



  43. POLMAN CH , Reingold SC, Banwell B, Clanet M, et al
    Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
    Ann Neurol. 2011;69:292-302.
    PubMed     Text format     Related articles    Abstract available



  44. RUDICK RA
    Diagnostic criteria in multiple sclerosis: Headed in the right direction but still a ways to go.
    Ann Neurol. 2011;69:234-6.
    PubMed     Text format     Related articles   



    January 2011
  45. CORREALE J , Villa A
    Role of CD8 regulatory T Cells in multiple sclerosis.
    Ann Neurol. 2011 Jan 19. doi: 10.1002/ana.22302.
    PubMed     Text format     Related articles   



  46. BARACCHINI C , Perini P, Calabrese M, Causin F, et al
    No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset.
    Ann Neurol. 2011;69:90-9.
    PubMed     Text format     Related articles    Abstract available



  47. GUNNARSSON M , Malmestrom C, Axelsson M, Sundstrom P, et al
    Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Ann Neurol. 2011;69:83-9.
    PubMed     Text format     Related articles    Abstract available



  48. COMI G , Cohen JA, Arnold DL, Wynn D, et al
    Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.
    Ann Neurol. 2011;69:75-82.
    PubMed     Text format     Related articles    Abstract available



  49. GOURRAUD PA , McElroy JP, Caillier SJ, Johnson BA, et al
    Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
    Ann Neurol. 2011;69:65-74.
    PubMed     Text format     Related articles    Abstract available



  50. HARDY J , Thompson AJ
    Dissecting the familial risk of multiple sclerosis.
    Ann Neurol. 2011;69:11-2.
    PubMed     Text format     Related articles   



  51. COHEN R , Blight AR
    4-Aminopyridine: new life for an old drug. Reply.
    Ann Neurol. 2011;69:218-20.
    PubMed     Text format     Related articles   



  52. SANDOVAL-GUTIERREZ JL , Arcos M, Alva L, Volkow P, et al
    A 2-year-old girl positive for 2009 AH1N1 pandemic influenza.
    Ann Neurol. 2011;69:217.
    PubMed     Text format     Related articles   



  53. WARNKE C , Adams O, Hartung HP, Kieseier BC, et al
    Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
    Ann Neurol. 2011;69:215-6.
    PubMed     Text format     Related articles   



    December 2010
  54. KHOURY S , Bakshi R
    Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis.
    Ann Neurol. 2010;68:778-9.
    PubMed     Text format     Related articles   



  55. MILLER RG , Barohn RJ, Dubinsky R
    Expanding the evidence base for therapeutics in myasthenia gravis.
    Ann Neurol. 2010;68:776-7.
    PubMed     Text format     Related articles   



  56. PETZOLD A , Mondria T, Kuhle J, Rocca MA, et al
    Evidence for acute neurotoxicity after chemotherapy.
    Ann Neurol. 2010;68:806-15.
    PubMed     Text format     Related articles    Abstract available



  57. GOTTLE P , Kremer D, Jander S, Odemis V, et al
    Activation of CXCR7 receptor promotes oligodendroglial cell maturation.
    Ann Neurol. 2010;68:915-24.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  58. BALASHOV KE , Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, et al
    Interferon-beta inhibits toll-like receptor 9 processing in multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  59. MANDAWAT A , Kaminski HJ, Cutter G, Katirji B, et al
    Comparative analysis of therapeutic options used for myasthenia gravis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  60. CAMPBELL GR , Ziabreva I, Reeve AK, Krishnan KJ, et al
    Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  61. ZAMBONI P
    Regarding "No Cerebrocervical Venous Congestion in Patients with Multiple Sclerosis. Intraluminal Jugular Septation"
    Ann Neurol. 2010.
    PubMed     Text format     Related articles   



  62. GEURTS JJ , Kooi EJ, Witte ME, van der Valk P, et al
    Multiple sclerosis as an "Inside-out" disease.
    Ann Neurol. 2010;68:767-8.
    PubMed     Text format     Related articles   



  63. JURYNCZYK M , Walczak A, Jurewicz A, Jesionek-Kupnicka D, et al
    Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
    Ann Neurol. 2010;68:593-601.
    PubMed     Text format     Related articles    Abstract available



  64. STEINMAN L , Zamvil SS
    Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosis.
    Ann Neurol. 2010;68:567-9.
    PubMed     Text format     Related articles   



  65. DAMMANN O , Leviton A
    The challenge of causal inference.
    Ann Neurol. 2010;68:770.
    PubMed     Text format     Related articles   



  66. APIWATTANAKUL M , Popescu BF, Matiello M, Weinshenker BG, et al
    Intractable vomiting as the initial presentation of neuromyelitis optica.
    Ann Neurol. 2010;68:757-61.
    PubMed     Text format     Related articles    Abstract available



  67. ELBERS J , Halliday W, Hawkins C, Hutchinson C, et al
    Brain biopsy in children with primary small-vessel central nervous system vasculitis.
    Ann Neurol. 2010;68:602-10.
    PubMed     Text format     Related articles    Abstract available



  68. HUNDER GG , Salvarani C, Brown RD Jr
    Primary central nervous system vasculitis: Is it a single disease?
    Ann Neurol. 2010;68:573-4.
    PubMed     Text format     Related articles   



  69. PIORO EP , Brooks BR, Cummings J, Schiffer R, et al
    Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.
    Ann Neurol. 2010;68:693-702.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  70. STANKOFF B , Freeman L, Aigrot MS, Chardain A, et al
    Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(11) C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.
    Ann Neurol. 2010 Oct 29. doi: 10.1002/ana.22320.
    PubMed     Text format     Related articles    Abstract available



  71. GUNNARSSON M , Malmestrom C, Axelsson M, Sundstrom P, et al
    Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  72. RASMUSSEN S , Imitola J, Ayuso-Sacido A, Wang Y, et al
    Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22299.
    PubMed     Text format     Related articles    Abstract available



  73. KREFT KL , Verbraak E, Wierenga-Wolf AF, Laman JD, et al
    Role of CD8 regulatory T-cells in multiple sclerosis.
    Ann Neurol. 2010 Oct 28. doi: 10.1002/ana.22288.
    PubMed     Text format     Related articles   



  74. SIMKA M , Kazibudzki M
    Chronic cerebrospinal venous insufficiency and multiple sclerosis: A commentary.
    Ann Neurol. 2010;68:562-3.
    PubMed     Text format     Related articles   



  75. BEGGS C
    Multiple sclerosis appears To be associated with cerebral venous abnormalities.
    Ann Neurol. 2010;68:560-1.
    PubMed     Text format     Related articles   



  76. GOODMAN AD , Brown TR, Edwards KR, Krupp LB, et al
    A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
    Ann Neurol. 2010;68:494-502.
    PubMed     Text format     Related articles    Abstract available



  77. MAGLIOZZI R , Howell OW, Reeves C, Roncaroli F, et al
    A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
    Ann Neurol. 2010;68:477-93.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  78. BERGER JR , Centonze D, Comi G, Confavreux C, et al
    Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
    Ann Neurol. 2010;68:409-11.
    PubMed     Text format     Related articles   



  79. RYSCHKEWITSCH CF , Jensen PN, Monaco MC, Major EO, et al
    JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.
    Ann Neurol. 2010;68:384-91.
    PubMed     Text format     Related articles    Abstract available



  80. WEST TW , Cree BA
    Natalizumab dosage suspension: are we helping or hurting?
    Ann Neurol. 2010;68:395-9.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  81. ANDRODIAS G , Reynolds R, Chanal M, Ritleng C, et al
    Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  82. HANDEL AE , Lincoln MR, Ramagopalan SV
    Chronic cerebrospinal venous insufficiency and multiple sclerosis.
    Ann Neurol. 2010;68:270.
    PubMed     Text format     Related articles   



  83. SUNDSTROM P , Wahlin A, Ambarki K, Birgander R, et al
    Venous and cerebrospinal fluid flow in multiple sclerosis: A case-control study.
    Ann Neurol. 2010;68:255-9.
    PubMed     Text format     Related articles    Abstract available



  84. SIMPSON S JR , Taylor B, Blizzard L, Ponsonby AL, et al
    Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Ann Neurol. 2010;68:193-203.
    PubMed     Text format     Related articles    Abstract available



  85. DOEPP F , Paul F, Valdueza JM, Schmierer K, et al
    No cerebrocervical venous congestion in patients with multiple sclerosis.
    Ann Neurol. 2010;68:173-83.
    PubMed     Text format     Related articles    Abstract available



  86. CREE BA , Kornyeyeva E, Goodin DS
    Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
    Ann Neurol. 2010;68:145-50.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  87. KILLESTEIN J , Vennegoor A, Strijbis EM, Seewann A, et al
    Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  88. DARLINGTON PJ , Boivin MN, Renoux C, Francois M, et al
    Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  89. WEBER MS , Prod'homme T, Patarroyo JC, Molnarfi N, et al
    B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
    Ann Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available



  90. HAUSER SL , Johnston SC
    4-aminopyridine: new life for an old drug.
    Ann Neurol. 2010;68:A8-9.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: